Insight Molecular Diagnostics Inc. ( IMDX) - Key Metrics
IMDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.31 | -$0.25 | -$0.27 |
| 2026Q1 | $0 | -$0.12 | -$0.22 | -$0.24 |
| 2025Q4 | $0.04 | -$0.75 | -$0.18 | -$0.23 |
| 2025Q3 | $0.01 | -$0.34 | -$0.14 | -$0.17 |
| 2025Q2 | $0.02 | -$0.30 | -$0.20 | -$0.21 |
IMDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.76 |
| 2026Q1 | 0% | -6.83 |
| 2025Q4 | 0% | -2.50 |
| 2025Q3 | 0% | -2.44 |
| 2025Q2 | 0% | -2.48 |
IMDX
Price: $4.13
52 week price:
Earnings Per Share: -1.52 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 141.4 million